You just read:

Eiger BioPharmaceuticals Announces First Patient Dosed in Phase 2 ULTRA Study of Ubenimex in Secondary Lymphedema

News provided by

Eiger BioPharmaceuticals, Inc.

Jul 25, 2016, 08:00 ET